{"transactions":[{"id":726637,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2026-06-25T20:01:48.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":4.08,"value":114240.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the first anniversary of the grant date, subject to the reporting person's continued service on the board of directors."}],"balance_after":28000,"derivative":{"exercise_price":4.08,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001180763-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000118076326000005/primarydocument.xml","form_type":"4"}},{"id":901270,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-02-17T13:24:46.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Unless otherwise terminated as provided in the optionee's option agreement, 12/48ths of the shares subject to the option shall vest twelve months after the Vesting Commencement Date, and 1/48th of the shares subject to the option shall vest on the same calendar day of each subsequent month thereafter until the shares subject to the option are fully vested."}],"balance_after":92000,"derivative":{"exercise_price":2.76,"expiration_date":"2036-02-03","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001180763-26-000002","document":"wk-form4_1771334683.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000118076326000002/wk-form4_1771334683.xml","form_type":"4"}},{"id":1108249,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-17T20:27:20.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":4.79,"value":119750.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":4.79,"exercise_date":"2026-06-17","expiration_date":"2035-06-16","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001562180-25-004902","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000156218025004902/primarydocument.xml","form_type":"4"}},{"id":1467353,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-06-28T20:04:41.000Z","date":"2024-06-26","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":5.52,"value":88320.0,"ownership":{"direct":true},"balance_after":16000,"derivative":{"exercise_price":5.52,"exercise_date":"2025-06-26","expiration_date":"2034-06-25","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001562180-24-005359","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000156218024005359/primarydocument.xml","form_type":"4"}},{"id":1540163,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-17T22:01:45.000Z","date":"2024-04-15","kind":"grant","planned":false,"acquired":true,"shares":295300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as to 25% of the underlying shares on October 15, 2024 and thereafter in substantially equal monthly installments such that the stock options shall be fully vested on the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":295300,"derivative":{"exercise_price":11.01,"expiration_date":"2034-04-15","underlying":"Common Stock","underlying_shares":295300},"source":{"system":"sec-edgar","filing":"0001493152-24-015067","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000149315224015067/ownership.xml","form_type":"4"}},{"id":1746892,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2023-11-09T01:31:56.000Z","date":"2023-11-07","kind":"exercise","planned":true,"acquired":false,"shares":1172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest in sixteen (16) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the issuer on each such vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest in sixteen (16) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the issuer on each such vesting date. The RSUs have no expiration date."}],"balance_after":15236,"derivative":{"underlying":"Common Stock","underlying_shares":1172},"source":{"system":"sec-edgar","filing":"0001694665-23-000176","document":"wk-form4_1699493502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000169466523000176/wk-form4_1699493502.xml","form_type":"4"}},{"id":1746891,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-11-09T01:31:56.000Z","date":"2023-11-08","kind":"sale","planned":true,"acquired":false,"shares":172,"price":0.33,"value":56.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction entered into by the Reporting Person, solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $0.32 to $0.34, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4."}],"balance_after":17758,"source":{"system":"sec-edgar","filing":"0001694665-23-000176","document":"wk-form4_1699493502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000169466523000176/wk-form4_1699493502.xml","form_type":"4"}},{"id":1746890,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-11-09T01:31:56.000Z","date":"2023-11-07","kind":"exercise","planned":true,"acquired":true,"shares":1172,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":17930,"source":{"system":"sec-edgar","filing":"0001694665-23-000176","document":"wk-form4_1699493502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000169466523000176/wk-form4_1699493502.xml","form_type":"4"}},{"id":1771630,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2023-09-29T20:02:17.000Z","date":"2023-09-27","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested as to 25% of the underlying shares on the grant date of September 27, 2023, with the remaining shares vesting in twelve (12) equal quarterly installments such that all of the RSUs will become vested on the third anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested as to 25% of the underlying shares on the grant date of September 27, 2023, with the remaining shares vesting in twelve (12) equal quarterly installments such that all of the RSUs will become vested on the third anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date. The RSUs have no expiration date."}],"balance_after":45000,"derivative":{"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001694665-23-000160","document":"wk-form4_1696017728.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000169466523000160/wk-form4_1696017728.xml","form_type":"4"}},{"id":1771629,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2023-09-29T20:02:17.000Z","date":"2023-09-27","kind":"grant","planned":true,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested as to 25% of the underlying shares on the grant date of September 27, 2023, with the remaining shares vesting in twelve (12) equal quarterly installments such that all of the RSUs will become vested on the third anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested as to 25% of the underlying shares on the grant date of September 27, 2023, with the remaining shares vesting in twelve (12) equal quarterly installments such that all of the RSUs will become vested on the third anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date. The RSUs have no expiration date."}],"balance_after":60000,"derivative":{"underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001694665-23-000160","document":"wk-form4_1696017728.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000169466523000160/wk-form4_1696017728.xml","form_type":"4"}},{"id":1771628,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-09-29T20:02:17.000Z","date":"2023-09-28","kind":"sale","planned":true,"acquired":false,"shares":1996,"price":3.94,"value":7864.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction entered into by the Reporting Person on December 7, 2022, solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $3.92 to $3.94, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4."}],"balance_after":16758,"source":{"system":"sec-edgar","filing":"0001694665-23-000160","document":"wk-form4_1696017728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000169466523000160/wk-form4_1696017728.xml","form_type":"4"}},{"id":1771627,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-09-29T20:02:17.000Z","date":"2023-09-27","kind":"exercise","planned":true,"acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":18754,"source":{"system":"sec-edgar","filing":"0001694665-23-000160","document":"wk-form4_1696017728.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000169466523000160/wk-form4_1696017728.xml","form_type":"4"}},{"id":1812183,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2023-08-10T00:43:24.000Z","date":"2023-08-07","kind":"exercise","planned":true,"acquired":false,"shares":1171,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest in sixteen (16) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the fourth anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest in sixteen (16) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the fourth anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date. The RSUs have no expiration date."}],"balance_after":16408,"derivative":{"underlying":"Common Stock","underlying_shares":1171},"source":{"system":"sec-edgar","filing":"0001694665-23-000135","document":"wk-form4_1691628193.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000169466523000135/wk-form4_1691628193.xml","form_type":"4"}},{"id":1812182,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-08-10T00:43:24.000Z","date":"2023-08-08","kind":"sale","planned":true,"acquired":false,"shares":342,"price":9.51,"value":3252.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction entered into by the Reporting Person on December 7, 2022, solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices within the range of $9.08 to $9.55, inclusive. The reporting person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4."}],"balance_after":3754,"source":{"system":"sec-edgar","filing":"0001694665-23-000135","document":"wk-form4_1691628193.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000169466523000135/wk-form4_1691628193.xml","form_type":"4"}},{"id":1812181,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-08-10T00:43:24.000Z","date":"2023-08-07","kind":"exercise","planned":true,"acquired":true,"shares":1171,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":4096,"source":{"system":"sec-edgar","filing":"0001694665-23-000135","document":"wk-form4_1691628193.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000169466523000135/wk-form4_1691628193.xml","form_type":"4"}},{"id":1846681,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T00:11:13.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16000,"derivative":{"exercise_price":8.7,"exercise_date":"2024-06-21","expiration_date":"2033-06-20","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001562180-23-005475","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000156218023005475/primarydocument.xml","form_type":"4"}},{"id":1859114,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T20:01:55.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Om March 17, 2023, the reporting person was granted an option to purchase 1,000,000 shares of the issuer's common stock subject to certain conditions, including the approval of the amendment and restatement of the Evelo Biosciences, Inc. 2018 Incentive Award Plan (the \"2018 Plan\") by stockholders at the issuer's 2023 Annual Meeting of Stockholders. The stockholders approved the amendment and restatement of the 2018 Plan on June 8, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in forty-eight (48) substantially equal installments at the end of each monthly anniversary of February 7, 2023, subject to the reporting person's continued service to the issuer on each such vesting date."}],"balance_after":1000000,"derivative":{"exercise_price":0.97,"expiration_date":"2033-03-16","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001694665-23-000081","document":"wk-form4_1686600107.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000169466523000081/wk-form4_1686600107.xml","form_type":"4"}},{"id":1898321,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-05-11T01:31:15.000Z","date":"2023-05-08","kind":"sale","planned":true,"acquired":false,"shares":3537,"price":0.1255,"value":443.8935,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction entered into by the Reporting Person on December 7, 2022, solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices within the range of $0.12 to $0.13, inclusive. The reporting person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4."}],"balance_after":58512,"source":{"system":"sec-edgar","filing":"0001694665-23-000051","document":"wf-form4_168376866026508.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000169466523000051/wf-form4_168376866026508.xml","form_type":"4"}},{"id":1898320,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2023-05-10T21:11:53.000Z","date":"2023-05-07","kind":"exercise","planned":false,"acquired":false,"shares":23437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in sixteen (16) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the fourth anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in sixteen (16) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the fourth anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date. The RSUs have no expiration date."}],"balance_after":351563,"derivative":{"underlying":"Common Stock","underlying_shares":23437},"source":{"system":"sec-edgar","filing":"0001694665-23-000046","document":"wf-form4a_168375309729647.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000169466523000046/wf-form4a_168375309729647.xml","form_type":"4/A","original_submission_date":"2023-05-09"}},{"id":1899708,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2023-05-09T20:09:17.000Z","date":"2023-05-07","kind":"exercise","planned":false,"acquired":true,"shares":23437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in sixteen (16) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the fourth anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date. The RSUs have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in sixteen (16) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the fourth anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date. The RSUs have no expiration date."}],"balance_after":351563,"derivative":{"underlying":"Common Stock","underlying_shares":23437},"source":{"system":"sec-edgar","filing":"0001694665-23-000043","document":"wf-form4_168366293877236.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000169466523000043/wf-form4_168366293877236.xml","form_type":"4"}},{"id":1899707,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-05-09T20:09:17.000Z","date":"2023-05-07","kind":"exercise","planned":false,"acquired":true,"shares":23437,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":62049,"source":{"system":"sec-edgar","filing":"0001694665-23-000043","document":"wf-form4_168366293877236.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000169466523000043/wf-form4_168366293877236.xml","form_type":"4"}},{"id":2024944,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2023-02-09T21:38:30.000Z","date":"2023-02-07","kind":"grant","acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units vest in sixteen (16) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the fourth anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units vest in sixteen (16) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the fourth anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date."}],"balance_after":375000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001694665-23-000015","document":"wf-form4_167597869228821.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000169466523000015/wf-form4_167597869228821.xml","form_type":"4"}},{"id":2024943,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-09T21:38:30.000Z","date":"2023-02-07","kind":"grant","acquired":true,"shares":1125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, subject to the reporting person's continued service to the issuer on each such vesting date."}],"balance_after":1125000,"derivative":{"exercise_price":0.97,"expiration_date":"2033-02-07","underlying":"Common Stock","underlying_shares":1125000},"source":{"system":"sec-edgar","filing":"0001694665-23-000015","document":"wf-form4_167597869228821.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000169466523000015/wf-form4_167597869228821.xml","form_type":"4"}},{"id":2159501,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2022-09-15T00:59:49.000Z","date":"2022-09-12","kind":"exercise","acquired":false,"shares":82000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested as to 25% of the underlying shares of common stock on July 25, 2018,  and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option was fully vested."}],"balance_after":107188,"derivative":{"exercise_price":0.73,"expiration_date":"2027-11-01","underlying":"Common Stock","underlying_shares":82000},"source":{"system":"sec-edgar","filing":"0001562180-22-006673","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000156218022006673/primarydocument.xml","form_type":"4"}},{"id":2159500,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-15T00:59:49.000Z","date":"2022-09-13","kind":"gift","acquired":false,"shares":47939,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a bona fide gift of Common Stock to a non-profit educational institution."}],"balance_after":34061,"source":{"system":"sec-edgar","filing":"0001562180-22-006673","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000156218022006673/primarydocument.xml","form_type":"4"}},{"id":2159499,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-15T00:59:49.000Z","date":"2022-09-12","kind":"exercise","acquired":true,"shares":82000,"price":0.73,"value":59860.0,"ownership":{"direct":true},"balance_after":82000,"source":{"system":"sec-edgar","filing":"0001562180-22-006673","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000156218022006673/primarydocument.xml","form_type":"4"}},{"id":2224348,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2022-06-23T00:59:33.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16000,"derivative":{"exercise_price":13.81,"exercise_date":"2023-06-21","expiration_date":"2032-06-20","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001562180-22-005315","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000156218022005315/primarydocument.xml","form_type":"4"}},{"id":2428949,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-21T21:42:45.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options will vest in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, subject to continued employment on such dates."}],"balance_after":300000,"derivative":{"exercise_price":5.05,"expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001694665-22-000011","document":"wf-form4_164280134938377.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000169466522000011/wf-form4_164280134938377.xml","form_type":"4"}},{"id":2634171,"issuer":{"id":5820,"kind":"organization","name":"Foghorn Therapeutics Inc.","symbol":"FHTX"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-14T20:53:07.000Z","date":"2021-07-13","kind":"grant","acquired":true,"shares":12530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in full on the first anniversary of the date of grant, subject to the director's continued service on our Board of Directors."}],"balance_after":12530,"derivative":{"exercise_price":9.4,"exercise_date":"2022-07-13","expiration_date":"2031-07-12","underlying":"Common Stock","underlying_shares":12530},"source":{"system":"sec-edgar","filing":"0001562180-21-004933","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000156218021004933/primarydocument.xml","form_type":"4"}},{"id":2890593,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-29T22:34:28.000Z","date":"2021-01-27","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options will vest in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, subject to continued employment on such dates."}],"balance_after":275000,"derivative":{"exercise_price":16.65,"expiration_date":"2031-01-27","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001694665-21-000026","document":"wf-form4_161195965391476.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000169466521000026/wf-form4_161195965391476.xml","form_type":"4"}},{"id":3297815,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-30T21:17:13.000Z","date":"2020-01-28","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options will vest in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, subject to continued employment on such dates."}],"balance_after":250000,"derivative":{"exercise_price":7.06,"expiration_date":"2030-01-27","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001694665-20-000004","document":"wf-form4_158041901328960.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000169466520000004/wf-form4_158041901328960.xml","form_type":"4"}},{"id":3694636,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-16T13:54:07.000Z","date":"2019-01-14","kind":"grant","acquired":true,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options will vest as to 25% of the total grant on the first anniversary of the grant date with the remainder vesting in equal quarterly installments over a three-year period thereafter, subject to continued employment on such dates."}],"balance_after":220000,"derivative":{"exercise_price":13.71,"expiration_date":"2029-01-14","underlying":"Common Stock","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0001694665-19-000004","document":"wf-form4_154764683002118.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000169466519000004/wf-form4_154764683002118.xml","form_type":"4"}},{"id":3939103,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":35426,"kind":"person","name":"GILL SIMBA","position":1,"cik":"0001180763","reported_name":"GILL SIMBA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option","published_at":"2018-05-10T22:06:24.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":145869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the grant date and vests in equal quarterly installments over a three year period thereafter."}],"balance_after":145869,"derivative":{"exercise_price":16,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":145869},"source":{"system":"sec-edgar","filing":"0000899243-18-012420","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1180763/000089924318012420/doc4.xml","form_type":"4"}}]}